DC42, a Ras-related small GTP binding protein, is involved in diverse cellular functions in lymphocytes. We generated transgenic mice expressing constitutively active murine CDC42 (Q61L) ) in peripheral lymph organs, spleen and lymph node, were also dramatically reduced, and exhibited massive apoptosis. Expression of Fas and Fas ligand on both thymocytes and peripheral T cells was upregulated in transgenic mice, but the increased apoptosis in the thymus was independent of Fas (CD95), whereas peripheral spleen and lymph node T cell apoptosis was Fas dependent. Thus, activated CDC42 triggers distinct apoptotic pathways in thymocytes and peripheral T cells.
Introduction
The primary functions of Rho family of GTP-binding proteins, Rho, Rac and CDC42, are key regulator of the actin cytoskeleton (Hall, 1998) . Recent studies have revealed many other cellular functions mediated by this family of proteins, such as stimulating transcription of a subset of genes and subsequent cell cycle progress (Hill et al., 1995) , T cell polarization and invasion (Habets et al., 1994; Stowers et al., 1995) and cell apoptosis (Chuang et al., 1997; Lores et al., 1997; Moorman et al., 1996) . In vivo mice lacking Rho function in the thymus through the overexpression of C. botulinum C3 transferase are de®cient in CD25 + pro-T cells due to the reduced survival of prothymocytes . In the adult thymus, loss of Rho function leads to defects of maturation, proliferation and cell survival during T cell development that impair the generation of normal numbers of thymocytes and mature peripheral T cells . Conversely, expression of constitutively activated Rac2 in the thymus results in increased T cells apoptosis (Lores et al., 1997) . Similar to Rac2, overexpression of a constitutively active form of CDC42 in Jurkat cells also initiates an apoptotic signaling pathway (Chuang et al., 1997) . But the mechanism of small G protein induced apoptosis is not well elucidated. The downstream signaling pathways of this family of proteins were also shown to be diverse. CDC42/Rac have recently been shown to activate NF-kB and the stress activated MAP kinase pathway JNK/SAPK and p38 (Bagrodia et al., 1995; Coso et al., 1995; Minden et al., 1995; Perona et al., 1997) . The JNK/SAPK pathway is activated by various stress stimuli or cytokines and has been found to be involved in the integration of TCR and costimulatory signals during the activation of mature T cells (Su et al., 1994) . Studies in cell lines in vitro have shown that the balance between Ras-mediated and stress-induced MAP kinase pathways might control whether the cells proliferate or die (Xia et al., 1995) .
T cells develop in the thymus through a series of stages that can be de®ned by the expression of various surface markers (von Boehmer, 1988) . A choice between the ab and gd lineages is followed by decisions whereby ab thymocytes become either CD4 + or CD8 + single positive cells (SP), which total approximately 15% of total thymocytes. These SP mature thymocytes are derived, through positive and negative selection, from CD4 + CD8
+ double positive cells (DP) which comprise of about 80% of the total thymocytes. The remaining 3 ± 5% of thymocytes do not express CD4 and CD8 and are termed double negative cells (DN). This DN subset can be further divided into four distinct precursor populations based on the expression of CD25 and CD44. 
CD25
7 (late pre-T cells) respectively (Godfrey et al., 1993) . The development of thymocytes from DN T cells to DP T cells depends on the signals mediated by the preTCR formed by TCR b chain and pre-Ta. Further development from DP T cells into single CD4 + and CD8
+ cells depends on the interaction between the mature TCR ab complex and MHC I and II in the thymus. This interaction leads to the selection (positive and negative) and maturation of ab lineage T cells.
Fas (CD95) is a TNFR family receptor and expressed constitutively on T cells and some other tissues as well (Nagata and Golstein, 1995) . Intracellular domain of Fas contains a death domain, which will recruit another death domain containing protein, FADD, upon ligand binding. Consequently, FADD binds Caspase 8 via their DED domain and triggers apoptosis pathway (Boldin et al., 1996; Muzio et al., 1996) . The ligand of Fas, FasL, shares homologue with other TNF superfamily ligands. Unlike Fas, the expression of FasL is primarily expressed on activated T cells and its expression is highly regulated upon T cell activation. Therefore, Fas/FasL mediated cell death pathway is involved in T cell activation induced cell death (AICD), an essential process for maintenance of T cell homeostasis in immune system. Mutation of Fas (Ipr) and FasL (gld) in mice and humans leads to severe autoimmune disease.
In the present study, we introduced a constitutively activated form of CDC42 (Q61L), into the T cells of transgenic mice to examine the eects of activated CDC42 on T cell development and apoptosis. Transgenic mice showed dramatic reduction of mature TCR ab T cells, accompanied by massive cell apoptosis. The increased T cell apoptosis correlates with the upregulation of death molecules, Fas and FasL on the cell surface. Further analysis showed that activated CDC42-induced T cell apoptosis in the thymus is Fas independent, while peripheral T cell apoptosis required Fas expression, suggesting that CDC42-induces apoptosis through a dierent mechanism in thymocytes than in peripheral T cells.
Results

Characterization of transgenic mice expressing a constitutively activated form of murine CDC42 in T cells
Replacement of Gln61 with Leu creates a mutant CDC42 molecule that lacks GTPase activity and acts as a constitutively activated small G protein (Bourne and McCormick, 1991) . To examine the role of CDC42 in T cell development and function in vivo, we generated transgenic mice expressing this mutated active form of CDC42 (Q61L) in T cells under the control of the human CD2 promoter (Zhumanekov et al., 1995) (Figure 1A ). The expression of CDC42 (Q61L) in these transgenic mice was initially examined by RT ± PCR, using a forward primer speci®c to the mini-exon of the CD2 and a reverse primer speci®c for CDC42; the product of this PCR is derived from the transgene and therefore only detects mutant CDC42 ( Figure 1a ). As shown in Figure 1B , both the thymus and the peripheral lymphoid organs (spleen and lymph node), expressed mutant CDC42 mRNA. The expression of CDC42 was further examined by Western blot analysis using a polyclonal antibody to CDC42. To examine CDC42 protein expression, equal amounts of sorted Thy1.2 + cell extracts were analysed by Western blot analysis, which showed increased CDC42 protein expression ( Figure 1C ).
The thymus of CDC42 transgenic mice was strikingly small compared to the WT littermates; both thymus weight and thymocyte number were reduced fourfold (Figure 2A ). Histological sections of these small thymi showed a severe disruption of normal morphology with disorganized medulla ( Figure 2B ,C). However, peripheral lymphoid organs, such as spleen, did not show signi®cant size dierences between transgenic and wild type animals (not shown).
Consistent with the small thymus size, the total number of thymocytes of transgenic mice was about fourfold less than that in control mice (Table 1) . To explore the developmental status and cellularity in the transgenic mice, we analysed CD4 and CD8 expression by thymocytes from both control and transgenic mice bȳ ow cytometry. Thymocyte development, assessed by measuring the number of cells bearing CD4 and CD8 coreceptors, was shown to be perturbed by the CDC42 
CD8
7 DN thymocytes was observed compared with WT littermate (4%). Second, the percentage of CD4 + CD8
+ DP cells was reduced from 80% to about 55% ( Figure 3) . Third, the percentage of mature SP cells, particularly CD4 + , was decreased about threefold (14.5% vs 4.5%; Figure 3A ). The decrease in total thymocytes (39610 6 in transgenic mice vs 170610 6 in the control) was re¯ected in the reduction of each individual subset except for CD4 7 CD8 7 DN which were increased dramatically. Table 1 shows that the total number of DP and CD4 + SP cells was decreased sevenfold, whereas CD8 + SP cells were decreased about twofold. In contrast, DN cells were increased 2.5-fold. With the reduction of CD4 + and CD8 + SP cells in the thymus, the peripheral T cell numbers in both spleen and lymph node were also dramatically reduced ( Figure 3 , mid and lower panel). These data show that activated CDC42 not only disturbed thymocyte development but also reduced T cell numbers in both thymus and peripheral lymph organs. 
7 DN subsets in control and transgenic mice. Absolute cell number in each individual CD44/CD25 subpopulations was calculated on the basis of percentage obtained and total numbers of CD4 7
7 DN thymocytes in control and transgenic mice CDC42 mediated apoptosis in T cells S Na et al population remained similar or slightly reduced ( Figure 4A,B) . To understand the possible underlying mechanism for the increase of DN thymocyte, we examined cell proliferation by measuring in vivo BrdU incorporation ( Figure 5 ). It is evident that DN thymocyte from CDC42 transgenic mice proliferated more than WT thymocytes, suggesting that CDC42 stimulated cell proliferation which could contribute to the increased DN thymocyte in transgenic mice. 
CDC42 induces T cell apoptosis and stimulates JNK activity
In principle, the reduction in total thymocyte and peripheral T cell number observed in CDC42 transgenic mice could result from decreased production or increased destruction (apoptosis) of these cells. To examine the molecular basis for the decreased thymus cellularity, we examined apoptosis in these CDC42 transgenic mice using both Annexin V staining and the TUNEL assay. An early hallmark of apoptotic cells is the translocation of phosphatidylserine from the inside to the outside of the plasma membrane, which can be readily detected by Annexin V binding (Martin et al., 1995) . At later stages of the apoptotic process, the DNA is fragmented and can be detected by the TUNEL assay (Gavrieli et al., 1992) . As shown in Figure 6a , 45 ± 50% of the T cells from the thymus, spleen and lymph node were Annexin V positive compared with 2 ± 24% in the control mice, indicating that many T cells in the transgenic mice are apoptotic. The increased apoptosis in the transgenic mice was further visualized by the TUNEL assay in thymus sections. Consistent with the Annexin V staining, a larger number of thymocytes were TUNEL positive in the transgenic mice than in control mice (Figure 6b) .
Recently, a number of reports have shown that the JNK signaling pathway is stimulated by the small GTPases, Rac and CDC42 (Coso et al., 1995; Minden et al., 1995) . To address the possibility of JNK activation by CDC42 in vivo, we measured the JNK and p38 MAP kinase activity from both control and transgenic mice. As determined by direct analysis of c-Jun phosphorylation by JNK and ATF2 by p38 MAP kinase, JNK activity was increased about ®vefold, whereas p38 MAP kinase activity remained similar or slightly increased in transgenic mice ( Figure 7 ). These data suggest that JNK pathway is activated by CDC42 in thymocytes in vivo, which might be involved in consequent upregulating Fas/ FasL expression.
CDC42 upregulates Fas, FasL expression and induces peripheral T cell death through a Fas dependent mechanism
To understand the mechanism of increased T cell death in transgenic mice, we ®rst examined the T cell death factors ± Fas and FasL. Fas (CD95) is a death receptor, which is required for the elimination of self reactive or activated peripheral T cells (Nagata and Golstein, 1995) . We therefore considered that the increased T cell apoptosis in the transgenic mice could be mediated by the Fas/FasL pathway. We ®rst examined the cell surface expression of Fas/FasL using FACS analysis. Compared with WT littermates, the percentage of TCR ab T cells expressing high levels of Fas in transgenic mice was increased by three, four and sixfold in thymus, spleen and lymph node, respectively ( Figure  8 ). Similarly, Fas ligand expression was also increased in these respective organs by 2.4-, 6-and 17-fold (Figure 8 ). These results suggested that the increased T cell apoptosis in transgenic mice could be due to the increased expression of Fas and Fas ligand. To further determine the involvement of Fas in the apoptosis pathway induced by CDC42, we crossed CDC42 transgenic mice with lpr mice, and the resulting lpr/ lpr CDC42 Tg + mice were used to examine T cell apoptosis. Interestingly, T cell apoptosis in the peripheral lymphoid organs, spleen and lymph node was completely abolished by the elimination of Fas expression. However, thymocyte apoptosis was not aected in the lpr background ( Figure 6A ), and in fact both the thymus size and cell number remain the same as the transgenic mice (data not shown), indicating that the initial T cell apoptosis pathway induced by CDC42 appears to dier between thymus and peripheral lymphoid organs. On the other hand, blocking cell death in peripheral lymph organs in lpr/lpr CDC42-Tg mice resulted in an increase in T cell numbers in lymph node but not in spleen, compared with CDC42 Tg + alone, but still a signi®cantly lower number than WT mice (Table 2 ). These results suggest that both thymocyte maturation and peripheral T cell apoptosis contribute to peripheral T cell homeostasis.
Discussion
Small GTPases of both the Ras and Rho family have been shown to be directly involved in signaling during early T cell development Henning et al., 1997; Swan et al., 1995) . The present data show that signaling mediated by activated CDC42 also has a dramatic impact on T cell development and apoptosis. Here we showed that when constitutively activated CDC42 is expressed in T cells of transgenic mice, the CD4 7 CD8 7 DN cells are dramatically increased in comparison to the reduction of other thymocyte subpopulations including DP and CD4, CD8 SP thymocytes. Furthermore, the mature TCRab T cells are dramatically reduced due to increased expression of Fas/FasL and apoptosis at least in peripheral lymph organs. The majority of the increase in DN thymocytes occurs mainly at the CD25 + stage. The acquisition of CD25 expression by CD25 7 CD44 + cells has been shown to be accompanied by extensive proliferation, which is mediated by preTCR signaling (Levin et al., 1993) . Therefore, the increased CD25 + DN thymocyte in transgenic mice could be explained by the fact that these thymocytes are more proliferative than their non-transgenic counterparts, based on the fact that DN thymocyte showed higher BrdU incorporation in vivo ( Figure 5 ). This is consistent with the evidence that CDC42 (GTPase-defective mutant, G12V or Q61L and`fast cycling' mutant, F28L) can stimulate cell cycle and DNA synthesis (Lin et al., 1997; Olson et al., 1995 , 1997) ; it is tempting to speculate that these cells then become susceptible to apoptosis due to CDC42 activation and are more easily depleted, whereas their Bcl2 high precursors would be resistant. Obviously, further experiments are needed to address the mechanism whereby CDC42 acts in this developmental process.
In the immune system, apoptosis is essential for normal development, homeostasis and the establishment of immune self-tolerance (Abbas, 1996; Linette and Korsmeyer, 1994) . The death receptor Fas, which is constitutively expressed on T cells, is responsible for mature T cell apoptosis, whereas the cell death mechanisms in the thymus are not well understood (Nagata and Golstein, 1995) . Unlike Fas, FasL is not expressed on normal T cells but is induced for expression upon T cell activation with the exception of immune privilege sites such as eye and testis, which constitutively express FasL. Thymocytes that can interact with self-MHC are positively selected (positive selection) (von Boehmer, 1994) , whereas those with high avidity for self-MHC undergo apoptosis during negative selection (Nossal, 1994) . In the periphery, mature T cells undergo additional selection to eliminate those that interact with peripheral self antigen (peripheral clonal deletion) (Webb et al., 1994) . Recent evidence strongly indicates that the kinases upstream of the JNK pathway PAK and MEKK1, which are directly activated by CDC42/ Rac, are activated upon TCR and CD28 co-ligation in T cells (Avraham et al., 1998; Kaga et al., 1998) , and therefore CDC42/Rac activation might lead to T cell activation and cause activation induced cell death through the Fas-FasL pathway (Kabelitz et al., 1993) . Consistent with these previous ®ndings, our data clearly showed that activated CDC42 upregulates Fas and FasL expression (see Figure 6) , suggesting, therefore, that the cell death induced by CDC42 might be due to Fas-FasL upregulation. In fact, this is the case in peripheral lymph organs ( Figure 6 ). Lack of Fas expression in the lpr background completely eliminates the T cell apoptosis in spleen and lymph nodes in the transgenic mice ( Figure 6 ). We also found that CDC42 induced JNK activation. Together these results are consistent with the recent observations of Green and his colleagues who showed that JNK activation caused FasL expression (Faris et al., 1998; Kasibhatla et al., 1998) . On the other hand, we do not yet have a mechanism to explain the increased cell death in the thymus, which is Fas-FasL independent. Unlike peripheral lymph organs, the upregulation of Fas/FasL expression in thymus is minimal (Figure 8 ). This is consistent with the result from the lpr/lpr CDC42Tg + mice in which the thymocyte cell death is apparently not aected by the Fas mutation (Figure 6 ). Although caspases have been suggested to be speci®cally activated during negative selection (Alan et al., 1997) , Fas has been suggested not to be involved in negative selection, since negative selection in the thymus is apparently normal in lpr mice (Sidman et al., 1992) . Other TNFR family receptors such as CD30 have been suggested to be involved in negative selection; however the targets of CD30 signaling are unclear (Amakawa et al., 1996) . The fact that CDC42 induced apoptosis in the thymus is not dependent on Fas raised the possibility that CDC42 mediated signaling might be directly involved in negative selection in thymus. This is further supported by the observation that the mice lacking the Rho-family GTP exchange factor Vav display defects in positive and negative selection of thymocytes (Turner et al., 1997) .
Interestingly, the phenotype in our transgenic mice resembles that of the previously reported Rac2 transgenic mice, which showed enhanced apoptosis in thymus when overexpressed with active form of Rac2 (Lores et al., 1997) , suggesting that both Rac and CDC42 might trigger the same downstream signaling pathway. This is supported by the facts that both transgenic mice showed increased JNK kinase activity as well as apoptosis. However, whether Rac2 transgenic mice also upregulated Fas-FasL pathway was not addressed in the previous work (Lores et al., 1997) . Here, we further provided evidence that increased peripheral T cell apoptosis via Fas-FasL pathway: (1) Activated CDC42 upregulates both Fas and FasL expression on both thymocyte and peripheral T cells possible via JNK pathway; (2) Elimination of Fas expression in lpr background can abolish peripheral T cell death. These suggest that CDC42 might be involved in T cell activation induced cell death by Fas/FasL pathway in vivo.
The role of Rho family proteins in T cell apoptosis has been recently revealed by a number of studies. First, both Rac2 and CDC42 have been recently shown to be able to directly induce apoptosis when constitutively activated GTPases are introduced into transgenic T cells and Jurkat cells, respectively (Chuang et al., 1997; Lores et al., 1997) . Second, it has been shown that D4-GDI, a hematopoietic cell regulator of CDC42/Rac is rapidly cleaved by Caspase 3 during Jurkat T cell apoptosis, implying that the disrupted regulation of CDC42/Rac by D4-GDI during apoptosis may transiently activate GTPases (Na et al., 1996) . Third, CDC42/Rac have been demonstrated to activate the JNK signaling pathway which is also involved in apoptosis as demonstrated in PC12 cells (Xia et al., 1995) and JNK37/7 mice (Yang et al., 1997) . Nevertheless, here we show for the ®rst time that activated CDC42 is able to activate the JNK pathway in vivo and consequently upregulates Fas/FasL expression on cell surface and cell death, by a process known as Activation Induced Cell Death in T cells. On the other hand, we do not know yet the mechanism of cell death occurred in thymus by CDC42. It is possible that these small GTPases induce T cell apoptosis by activating JNK, which may then subsequently activate Caspases by an as yet unknown mechanism. This is consistent with our recent ®ndings that a dominant negative JNK1 transgene inhibits apoptosis of DN thymocytes in vivo (RincoÂ n et al., 1998) . Further eorts should be directed toward understanding the eector molecules, which connect small GTPases to the apoptotic machinery in T cells.
Materials and methods
Generation of transgenic mice
A constitutively active form of murine CDC42 cDNA (Q61L) was cloned in the EcoRI site of the human CD2 expression vector (Zhumanekov et al., 1995) in the orientation to be expressed under the control of human CD2 promoter, which directs speci®c expression in T cells of transgenic mice. The resulting plasmid was restricted with KpnI/XbaI to generate a 12 kb fragment containing the hCD2 promoter and the locus control region (LCR) driving CDC42 (Q61L). The puri®ed DNA fragment was then injected into fertilized C57BL/ 6XC3H F2 eggs and transgenic mice were generated as described previously (Hogan et al., 1986) . Founders were backcrossed onto C57BL/6 (Jackson Laboratories, Bar Harbor, ME, USA) to generate progeny for further studies. For generating lpr/lpr CDC42 (Q61L) transgenic mice, CDC42 (Q61L) transgenic mice were bred with MRL-lpr/ lpr mice, which were obtained from Jackson Laboratories. The progeny were screened by PCR for both CDC42 and lpr.lpr/lpr mice was screened using a three-primer PCR system as described before (Mehal and Crispe, 1998) . The primers CD9512FX (ACAGCATAGATTCATTTGCTGCT) and CD9512REV (TGAGTAATGGGCTCAGTGCAGCA) were complementary to regions 5' and 3' of the insertion in intron 2 that were responsible for the lpr genotype, generating a PCR product of *200 bp in the wild-type group but no product in the CD95-de®cient group. The primer CD95Z8XTR (CAAATTTTATTGTTGCGACAC-CA) was complementary to a region within the lpr insertion, generating a product of *250 bp in association with CD9512FX. CDC42-Tg mice were screened by PCR using the primers described below.
RNA preparation, PCR and RT ± PCR Transgenic mice were screened by PCR. For PCR screening, the forward primer, which is speci®c for a mini-exon located at the 3' end of the human CD2 promoter, was 5'-TGT AGC CAG CTT CCT TCT-3'; the reverse primer, which is speci®c for the 3' of the murine CDC42, was 5'-GCG AAT TCT CAT AGC ACA CAC CTG CG-3'. PCR CDC42 mediated apoptosis in T cells S Na et al reactions were carried out using tail DNA for 35 cycles (948C 30 s, 558C 45 s, 728C 45 s). For RT ± PCR, total RNA was puri®ed from thymocytes, splenocyte and lymph node using Trizole (Gibco Life Science Tech., Gaithersburg, MD, USA). RNA was reverse transcribed using random hexamer primer and cDNA was further used as the template for PCR using the speci®c primers as described above.
Western blot and kinase assays
Peripheral T cells from both control and transgenic mice were puri®ed by sorting Thy1.2 + T cells. Single suspension cells from spleen and lymph node were stained with B220, NK1.1, and Mac-1 Abs (Pharmingen, San Diego, CA, USA) and depleted with anti-rat IgG conjugated Biomeg (PerSeptive Biosystems, Framingham, MA, USA). The remaining T cells were stained with PE-Thy1.2 Ab (Pharmingen, San Diego, CA, USA) and sorted by FACS. Collected cells were subjected to lysis using buer A (20 mM Tris [pH 7.5], 10% glycerol, 1% Triton X-100, 0.137 M NaCl, 25 mM bglycophosphate, 2 mM EDTA, 0.5 mM dithiothreitol, 1 mM sodium orthovanadate, 2 mM Na pyrophospate, 10 mg of leupeptin/ml, 1 mM PMSF). The extract was centrifuged at 15 000 g for 15 min at 48C and the protein concentration was determined (Bio-Rad, Hercules, CA, USA) following the standard protocol. Equal amounts of protein were loaded on 14% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) gel. Immunoblot analysis was performed by probing with an antibody to CDC42 (Santa Cruz Biotech, Santa Cruz, CA, USA) and visualized by ECL (Amersham, Arlington Heights, IL, USA).
For the kinase activity assays, tissues were treated as above. Endogenous p38 and JNK were immunoprecipitated from 10 mg of extract by incubation for 5 h at 48C with polyclonal antibodies (Raingeaud et al., 1995) bound to protein A-Sepharose (Sigma, St. Louis, MO, USA). The immunoprecipitates were washed twice with buer A and twice with kinase buer (25 mM HEPES pH 7.4, 25 mM bglycerophosphate, 23 mM MgCl2, 0.5 mM dithiothreitol and 0.1 mM sodium orthovanadate). The protein kinase reactions were initiated by addition of 1 mg of recombinant substrate protein (GST-ATF2 for p38 and GST-Jun for JNK) and 50 mM [g-32 P]ATP (10 Ci/mmole) in a ®nal volume of 40 ml kinase buer. The reactions were terminated after 30 min at 308C by the addition of Laemmli sample buer. Phosphorylation of substrate proteins was examined by SDS ± PAGE by autoradiography and Phosphoimager analysis.
Flow cytometric analysis
Thymi, spleens and lymph nodes were obtained from 4 ± 6 week old mice. Tissues were squashed using frosted slides and forced through a ®ne nylon mesh to obtain a single cell suspension. Splenocytes additionally were subjected to hypotonic shock to lyse red blood cells. Total cell numbers were determined by counting trypan blue-stained cells using a Neubauer hemocytometer. Antibodies were conjugated tō uorescein isothiocyanate (FITC), phycoerythrin (PE), cytochrome (red) or biotin. Biotinylated antibodies were detected using streptavidin-Texas Red. All the mAbs were purchased from Pharmingen (San Diego, CA, USA): CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD25 (3C7), CD44 (IM7), ab TCR (H57-597), g/d TCR (GL3), B220 (RA3-6B2), NK1.1 (PK136), Thy1.2 (53-2.1), anti-Fas (Jo2), anti Fas ligand (MFL3). Cells ( 2610 6 ) were stained with antibodies at 48C for 45 min in a 96-well V-bottom shaped microtiter well plate in 100 ml of PBS containing 2% FCS. Stained samples were collected and analysed using a Dickinson FACStar plus. For the FITC-conjugated Annexin V staining, cells were stained as described above and then washed once with Annexin V staining buer (10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM Mg2C12 and 1.8 mM CaCl2), and ®nally stained with FITC-Annexin V (BioWhittaker Inc., Walkersville, MD, USA).
For the detection of in vivo incorporated BrdU, mice were provided drinking water containing 1 mg/ml BrdU for 2 days. Mice were then sacri®ced and thymocytes were prepared as described above. The thymocytes were initially stained with CD4 and CD8 and then stained with FITCconjugated BrdU Ab according to the manufacturer's instruction (Boehringer Mannheim, Indianapolis, IN, USA). Basically, cells were incubated with 2 M NaCl and 0.5% Triton X-100 at room temperature for 30 min. Cells were then washed and resuspended in PBS containing 1% BSA and 0.1% Tween 20 and Ab to BrdU. Samples were analysed by FACS.
Histology and TUNEL assay
Thymus and spleen sections were prepared for light microscopy by standard formalin/paran procedures and stained with hematoxylin and eosin. The sectioned thymus paran blocks were analysed for apoptotic cells in situ by the TdT-biotin nick end-labeling procedure using an Apoptag kit (Oncor Inc., Gaithersburg, MD, USA). Counterstaining was done with nuclear fast red (Sigma, St. Louis, and MO, USA).
Abbreviations PCR, polymerase chain reaction; DN, double negative; DP, double positive; SP, single positive; TCR, T cell receptor; JNK, c-jun N-terminus kinase.
